Elsevier,
Dementia Rehabilitation, October 2021, Pages 57-79
This book chapter advances SDGs 3 and 17 by outlining the common physical impairments found in people living with dementia, as well as evidence for treatments to maintain or improve physical function and prevent falls, in both community and residential settings.
Elsevier,
Current Opinion in Green and Sustainable Chemistry, Volume 31, October 2021
Global warming and climate change caused by an ever-increasing accumulation of atmospheric CO2 are reaching alarming levels. In order to address this issue, significant research effort has been dedicated to the development of carbon capture processes for sequestration or utilization of CO2. This article reviews recent advances in electrochemically mediated CO2 capture and release, contributing to SDGs 9 and 13.
Elsevier,
Current Opinion in Green and Sustainable Chemistry, Volume 31, October 2021
Hydrogen as a clean, reliable and potentially sustainable energy vector has attracted growing interest for promoting the sustainable development of both industry and society worldwide. Hydrogen is a rising enabler for a multisectorial transition toward a low-carbon economy based on renewable energy sources. In this article, the authors argue that hydrogen is a game changer and review the policy framework for a hydrogen economy, contributing to SDGs 7, 9 and 13.
Elsevier,
Current Opinion in Green and Sustainable Chemistry, Volume 31, October 2021
Energy production and CO2 emissions are strictly connected. One of the most efficient and straightforward mitigations to the climate change is the conversion of CO2 into chemicals that may play the role of energy vectors in a carbon-based energy cycle. Contributing to SDGs 9 and 13, this article briefly illustrates and discusses the main findings that have paved the way of CO2 conversion to fuels or fuel precursors by electrochemical methods using redox catalysts that may find concrete applications.
Elsevier,
Prostaglandins and Other Lipid Mediators, Volume 156, October 2021
This review focuses on the role of 7-ketocholesterol (7KCh) mediated neurodegenerative Alzheimer’s disease with emphasis on alterations in the lipid raft microdomain. In addition, current trends in the significant therapies related to 7KCh inhibition are highlighted.
